Craig Kevin James 4
4 · ATAI Life Sciences N.V. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Craig Kevin James
Chief Medical Officer
Transactions
- Award
Stock Option
2025-03-03+757,915→ 757,915 totalExercise: $1.50Exp: 2035-03-03→ Common Shares (757,915 underlying)
Footnotes (1)
- [F1]The stock option shall vest as to 25% on January 1, 2026, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.